A
$ Value
$21K
Shares
1,253
Price
$17
Filed
Feb 2
Insider
Name
Ruiz Briseno Andres
Title
See Remarks
CIK
0001983118
Roles
Officer
Transaction Details
Transaction Date
2025-11-28
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
26,466
Footnotes
The shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). | 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Filing Info
Ruiz Briseno Andres's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-30 | IDYA | A | $0 |
| 2025-11-28 | IDYA | A | $21K |
| 2024-11-29 | IDYA | A | $16K |
Other Insiders at IDYA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Beaupre Darrin
Chief Medical Officer
|
— | — | 2026-01-30 |
|
Hata Yujiro S
President and CEO
|
— | — | 2026-01-30 |
|
Snyder Douglas B.
SVP, General Counsel
|
— | — | 2026-01-30 |
|
WHITE MICHAEL ANTHONY
Chief Scientific Officer
|
— | — | 2026-01-30 |
|
Ruiz Briseno Andres
See Remarks
|
— | — | 2026-01-30 |
|
DORMAN STUART
Chief Commercial Officer
|
— | — | 2026-01-30 |
|
Bleharski Joshua
Chief Financial Officer
|
— | — | 2026-01-30 |